- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07766395
A Clinical Trial to Evaluate the Effects of a Powder Supplement in Supporting Lean Muscle Development, Hormone-Related Wellness, Digestive Comfort, Dermatologic Health, and Overall Wellness
This study will evaluate the effects of Clean Nutra's Shelf Builder Women's Creatine Powder on lean muscle development, hormone-related wellness, digestive comfort, dermatological health, and overall wellness. The study is a single-arm, open-label, virtual trial in which all 35 enrolled participants will use the test product once daily for eight weeks.
Participants will complete self-reported questionnaires at Baseline and at the end of Week 4 and Week 8 to assess changes in lean muscle development, muscular endurance, hormone-related wellness, digestive comfort, hair/nail/skin health, and overall wellness.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Patrick Renner
- E-mail: hello@citruslabs.com
Studie Locaties
-
-
Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89101
- Werving
- Citruslabs
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Be female.
- Be aged 21-45.
- Engages in structured physical activity ≥3 times per week, with each session lasting at least 30 minutes, (e.g., running, gym/strength training, cycling, team sports, fitness classes).
- Anyone with a menstrual cycle between 24-38 days.
- Anyone who has experienced concerns with at least two of the following, twice per week, over the past four weeks: Hair, skin, and nail health
- Bloating
- Symptoms of hormonal imbalance.
- Anyone with a BMI of 18.5 to 30 kg/m2.
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- If taking medications, other supplements, or herbal remedies targeted at lean muscle development, muscular endurance, digestive comfort, hormonal balance, or dermatological health, has been consistently taking for at least three months prior to starting the study, and is willing to maintain this routine for the study duration.
- Anyone who is willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.
- Resides in the United States.
Exclusion Criteria:
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and mental health disorders.
- Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries.
- Planning on introducing any products or any new forms of prescription medication or supplements that target lean muscle development, muscular endurance, digestive comfort, hormonal balance, or dermatological health for the study duration.
- Anyone who has been diagnosed with kidney disease and/or has previously or is currently taking diuretics or kidney medications.
- Anyone who has previously or is currently taking any hormone therapies.
- Anyone who is currently taking medications or supplements that contain zinc or iron.
- Anyone with any allergies or sensitivities to fish, eggs, or any of the study product ingredients.
- Anyone currently consuming products with creatine.
- Anyone diagnosed with a thyroid-related condition.
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
- Anyone who has a history of serious illness in the last three months.
- Anyone who has planned surgery during the study period.
- Anyone with a history of substance abuse.
- Anyone who is currently a smoker or has been a smoker in the past 3 months.
- Anyone who has stopped or started using hormonal birth control in the past 2 months.
- Anyone who is vegan and/or does not consume animal products for any reason.
- Anyone currently taking a weight loss medication, including but not limited to Wegovy, Mounjaro, and Ozempic.
- Currently undergoing hair treatment or using other hair growth/thickening products.
- Currently taking any prescription medication for hair loss.
- Anyone with any conditions that affect the hair or scalp (e.g., alopecia areata).
- Anyone who drinks heavily (8 or more alcoholic drinks per week).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Shelf Builder Women's Creatine Powder
|
All participants take one scoop (9 g) of Clean Nutra Shelf Builder Women's Creatine Powder mixed in 8 oz of cold water once daily with the first meal of the day for eight weeks.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Lean Muscle Development
Tijdsspanne: Baseline, Week 4, and Week 8
|
Self-reported change in lean muscle development assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Muscular Endurance
Tijdsspanne: Baseline, Week 4, and Week 8
|
Self-reported change in muscular endurance assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Digestive Comfort
Tijdsspanne: Baseline, Week 4, and Week 8
|
Self-reported change in digestive comfort assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Hair
Tijdsspanne: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Nail
Tijdsspanne: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Skin Health
Tijdsspanne: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Symptoms of Hormonal Imbalance
Tijdsspanne: Baseline, Week 4, and Week 8
|
Self-reported change in symptoms of hormonal imbalance assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Overall Health and Wellness
Tijdsspanne: Baseline, Week 4, and Week 8
|
Self-reported change in overall health and wellness assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Perceived Change in Lean Muscle Strength
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in lean muscle strength assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Exercise Performance
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in exercise performance assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Lean Muscle Development
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in lean muscle development assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Hair
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Nail
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Skin Health
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Mood
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in mood assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Energy Levels
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in energy levels assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Mental Clarity
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in mental clarity assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Digestive Health
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in digestive health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Bloating
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in bloating assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Digestive Comfort
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in digestive comfort assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Muscle Recovery
Tijdsspanne: Baseline, Week 4, and Week 8
|
Participant-perceived change in muscle recovery assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- 20834
- legacy-20834
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .